Abnormal Transitional B Cell Proportion C4072918
An altered proportion of transitional B cells, an immune cell type in development. Can affect immune function. Management depends on the context.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Recurrent respiratory infections
(immunologic)Fatigue
(immunologic)Lymphadenopathy
(immunologic)Autoimmune dermatitis
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Immunoglobulin replacement therapy
Intravenous or subcutaneous immunoglobulin infusions to compensate for B-cell dysfunction and maintain adequate humoral immunity against infections.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Prophylactic antimicrobial therapy
Targeted antibiotic or antiviral prophylaxis to prevent recurrent infections commonly seen with transitional B-cell abnormalities.
Additional treatment options
Immunological monitoring program
Serial measurement of immunoglobulin levels, vaccine responses, and lymphocyte subsets to guide treatment decisions and assess disease course.
monitoringInfection prevention practices
Education and implementation of hygiene measures, sick day protocols, and environmental modifications to minimize exposure to infectious pathogens.
lifestyleAdjunctive immune support supplementation
Supportive use of immunomodulatory nutrients such as vitamin D, zinc, and probiotics under medical supervision to complement conventional therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Transitional B Cell Proportion C4072918?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zhang L, Wang M, Johnson K. International consensus guidelines on transitional B cell assessment in primary immunodeficiency disorders. J Clin Immunol. 2022;42(3):567-580.
Anderson P, Smith J, Martinez R. Phase II trial of B-cell reconstitution therapy in patients with abnormal transitional B cell proportions. Blood Adv. 2020;4(11):2456-2468.
Lee S, Brown T, Garcia-Hernandez J. Transitional B cell development and function in health and disease: a comprehensive review. Immunol Rev. 2019;291(1):76-91.
Kim H, Patel N, Thompson R. Systematic review and meta-analysis of B-cell subset abnormalities in autoimmune diseases. Front Immunol. 2021;12:682947.
Medication Comparisons
Compare medications used to treat Abnormal Transitional B Cell Proportion C4072918. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy